WolfHouse Schemes is the technology transfer and commercialization practice of Jason Tennenhouse and Amanda Findlay. We have worked every seat at the tech transfer table: on the founding team that built a university commercialization engine, as the Entrepreneur in Residence coaching its faculty founders, as consultants to the licensing office itself, inside a licensed-IP startup carried through to acquisition, and behind the fund that finances what the engine produces. Our style of commercialization starts from a simple conviction: the IP is not the company. A technology becomes an enterprise when someone proves two chapters, efficacy and market, and then builds the brand, the team, and the capital path that let the rest of the story get written. Most of that record was built at Purdue, one of the most productive commercialization ecosystems in the world, and it now extends through foundations, blended partnerships, and a validation network spanning five Canadian provinces. The numbers below are the receipts.
Inside the engine
Work done as part of the commercialization institution itself: founding-team roles, EIR service, satellite networks, and engagements for the offices that protect and license university IP.
Inside the venture
The licensee's side of the table: operating roles in IP-based companies, and technology we invented, licensed, or carried toward market ourselves.
Around the engine
The capital, adoption networks, and classroom pipelines that decide whether licensed technology survives contact with the market.
Chronological and selective. A project earned its place only if it shows something about how technology becomes a company. Scrub the line or click any entry.
Amanda was one of five on the founding team that built the Purdue Foundry into the commercialization engine of the Purdue Research Foundation, progressing through three roles across client services and communications. During this tenure: NBIA Incubator Network of the Year (2014); startup formation from licensed IP tripled; and the era anchored the data behind Purdue's #12 overall and #1 ranking among public universities without a medical school in tech transfer (Milken Institute, 2017) and #3 nationally in startup creation (IPWatchdog 2020, AUTM data 2008 to 2018).
Case study: the engine itself
When the Purdue Foundry formed, Amanda was one of the five people who built it out, constructing the client services and communications machinery between faculty inventors and the market. The results of that era are public record: roughly 8 startups per year became 24, 25, and 27; a single fiscal year logged 272 invention disclosures, 140 U.S. patents, and about $7M in royalty income; the National Business Incubation Association named it Incubator Network of the Year in 2014. The engine she helped build has gone on to worldwide standing, ranked #1 among public universities without a medical school by the Milken Institute and #3 nationally in startup creation on the AUTM data covering her full tenure, and its successor, Purdue Innovates, now stewards a university ranked #4 in the country for issued patents. Her role was significant and shared: she did not run the Foundry, she helped build the machinery that produced its outcomes, which is precisely the kind of work most commercialization programs need and rarely find.
Partner in the team that invented compliant lower-limb prosthetics from indigenous rattan, micro-manufactured by basket weavers in Bangalore. The technology took first-place finishes and set a course record at the 2016 Cybathlon at ETH Zurich. Early-stage hardware IP carried from invention through manufacturing partnerships to a global proof point: the full arc this document is about, at small scale.
Co-founded FoundryX at the Purdue Research Foundation: the first satellite network of outside business talent assembled specifically to commercialize Purdue IP, with planned expansions to Silicon Valley, Chicago, New York, and Europe. The structural insight has aged well: the bottleneck in university commercialization is rarely the science, it is the supply of operators willing to stand next to it.
VP of Marketing and Design inside a Purdue-IP precision agriculture startup. Built the design and marketing departments, grew the team 4x, and helped carry the technology to 4.8M acres of 116 crop types worth nearly $6.5B in protected crop value. Named a Forbes 25 Most Innovative AgTech startup (2017); acquired by DTN in 2018. The technology shipped during this tenure is still in production today as DTN Smart Trap and DTN Scout across 300+ crops.
Case study: the other side of the table
Most consultants who advise technology transfer offices have never been the licensee. Spensa is the case study TTO buyers rarely get to see: a university spinout built on licensed Purdue IP, lived from inside through the entire commercial arc. The work was the unglamorous middle of commercialization, building the commercial face of a scientific instrument, hiring and growing the team 4x, designing the UX across ten software modules, and converting entomology into something a farm manager would pay for. The outcome chain is complete: Forbes top-25 recognition, an acquisition by DTN in 2018, and, the part that matters most seven years later, technology still alive in the market as DTN Smart Trap and DTN Scout. When we tell a faculty founder what the road looks like, it is because we have driven it.
Engaged by the Purdue Research Foundation's Office of Technology Commercialization as a brand and strategy consultant. The work repositioned OTC to be approachable to the founders and faculty it exists to serve, advised the creation of its fast-track licensing program, and proposed a new brand and an IP discovery application. Commercialization offices usually hire consultants to study their portfolio; this engagement was about the office itself, because an engine nobody wants to walk into licenses nothing.
Entrepreneur in Residence at Purdue Innovates, the Foundry's successor. Coached faculty principal investigators on dozens of pre-commercial technologies, each screened at $500M+ market potential before reaching the EIR desk. Helped shift the engagement model from advisory office hours toward embedded, cofounder-style work organized around a two-chapter story: prove efficacy, prove market validation, and use those two chapters to attract first customers, first talent, and first capital.
Case study: the engagement model
The standard EIR model is office hours: a founder books a slot, describes a problem, receives advice, and the meter resets. The model practiced at Purdue Innovates treated the EIR as a temporary cofounder instead, embedded in a small number of ventures with the autonomy to do the work rather than describe it. The organizing doctrine was a story with two chapters. Chapter one proves the technology does what the paper says (efficacy). Chapter two proves someone outside the lab will pay for it (market validation). A venture that can tell both chapters can recruit its first customers, first talent, and first investment; a venture that cannot is a grant in a company costume. The thinking has outlived the residency: in 2026 WolfHouse delivered a two-phase communication and strategy engagement for Purdue Innovation and Entrepreneurship, with a further phase in discussion.
Founding Partner and Director of Flywheel Fund Greater Lafayette: led raising the initial fund from roughly 12 LPs, most of them first-time investors, with 4 startups deployed at a combined $40M in post-money valuations. The portfolio reads like a tech transfer syllabus: Amplified Sciences, a Purdue-IP diagnostics company now enrolling patients in a multicenter clinical study, and Uniform Sierra Aerospace, acquired by Flock Safety in January 2025. Universities complain that licensed technologies die in the capital gap. We built a fund that sits in it.
A two-phase paid engagement for Purdue Innovation and Entrepreneurship: Phase 1 developed the communication strategy; Phase 2 delivered a strategic white paper, presented in May 2026, with a third phase in discussion. Seventeen years after Amanda joined the Foundry founding team, the same university's innovation enterprise is still hiring this practice. Longevity inside one of the world's most productive commercialization ecosystems is its own credential.
AIVA, the Agricultural Innovation Validation and Adoption Network, launched publicly in May 2026 after an 18-month approval process, with WolfHouse principals among the team that designed it and leading execution within it. A blended nonprofit partnership rather than a university office, AIVA runs the last mile of tech transfer: nine validation projects selected, and an Early Adoption Farmer Alliance of 25 farms representing 300,000 acres across five Canadian provinces, moving innovations from developers to working farms. Tech transfer does not end at the license; it ends at adoption, and AIVA is that thesis at scale.
We have licensed it out, built on it, funded it, and taught it.
The seven capabilities commercialization programs hire for, mapped against where we have actually worked.
Where the ventures we have built, coached, licensed, or funded actually sit, mapped against the domains a university commercialization portfolio licenses across. Weighted by share of ventures touched, not revenue.15
Directional shares across the full venture history of both principals; counts deduplicated, not audited. Hover any wedge for representative ventures.
The record above is the firm. If your office is weighing an EIR program, a portfolio triage, a repositioning, a validation network, or the strategy that connects them, the first conversation carries no charge.
Engagements run from a standalone diagnostic to full program design to an operating retainer that keeps the commercialization engine tuned, the way these programs are meant to work and rarely do.